ON DEMAND WEBINAR
Duration: 1 hour

The past few years have seen exciting advances in the field of vaccinology, including developments in vaccine technology. 

These advances mean more options for providers, patients and policy makers — and more opportunities for pharma to leverage the latest technologies to develop novel protein-based vaccines. During this webinar, you will have the opportunity to learn about: 

• How vaccine technology — particularly recombinant protein vaccine technology — has advanced in recent years.
• How protein-based vaccines and saponin-based adjuvants work, and how they may help achieve a robust immune response.
• What pharma should consider today to develop the diverse vaccine portfolio of tomorrow and what the future holds. 

SPEAKERS

Robert Walker, MD
Senior Vice President and Chief Medical Officer
Novavax

 

Lisa M. Dunkle, MD
Vice President, Clinical Development, Global Medical Lead, Coronavirus Vaccine
Novavax

​​COR-NCS--0018 02/24